ReP USP - Resultado da busca

Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group (2023)

Ilário, Eder Nisi ; Bastos, Diogo Assed; Guglielmetti, Giuliano Betoni ; Murta, Claudio Bovolenta; Cardili, Leonardo ; Cordeiro, Mauricio Dener; Pontes Junior, José ; Coelho, Rafael Ferreira; Nahas, Willian Carlos

Source: Clinical genitourinary cancer. Unidade: FM

Subjects: NEOPLASIAS PROSTÁTICAS, PROSTATECTOMIA, METANÁLISE

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT
ILÁRIO, Eder Nisi et al. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group. Clinical genitourinary cancer, v. 21, n. 1, p. 43-54, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53755. Acesso em: 16 fev. 2026.
APA
Ilário, E. N., Bastos, D. A., Guglielmetti, G. B., Murta, C. B., Cardili, L., Cordeiro, M. D., et al. (2023). Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group. Clinical genitourinary cancer, 21( 1), 43-54. doi:10.1016/j.clgc.2022.10.009
NLM
Ilário EN, Bastos DA, Guglielmetti GB, Murta CB, Cardili L, Cordeiro MD, Pontes Junior J, Coelho RF, Nahas WC. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group [Internet]. Clinical genitourinary cancer. 2023 ; 21( 1): 43-54.[citado 2026 fev. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53755
Vancouver
Ilário EN, Bastos DA, Guglielmetti GB, Murta CB, Cardili L, Cordeiro MD, Pontes Junior J, Coelho RF, Nahas WC. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group [Internet]. Clinical genitourinary cancer. 2023 ; 21( 1): 43-54.[citado 2026 fev. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53755

Resposta patológica e marcadores imuno-histoquímicos no câncer de próstata localizado de alto risco tratado com terapia neoadjuvante e prostatectomia radical (2023)

Cardili, Leonardo; Leite, Katia Ramos Moreira (Orientador)

Unidade: FM

Subjects: IMUNOHISTOQUÍMICA, NEOPLASIAS PROSTÁTICAS

USP Schools

ReP

Filtros

Authors

USP affiliated authors